Recent REPROCELL News

REPROCELL News

Yokohama, Japan: REPROCELL is delighted to announce the launch a new service for consumers, Personal iPS, in which induced pluripotent stem cells (iPSCs) are established for future regenerative medicine treatment.

Continue reading →

Clinical Capabilities


REPROCELL is pleased to announce that the first patient has been registered and the test article administered at Nagoya University in the Phase II clinical trial of the regenerative medicine product Stemchymal®.

Continue reading →

Clinical Capabilities


Recent REPROCELL News